Trademark applications and grants for Blueprint Medicines Corporation. Blueprint Medicines Corporation has 24 trademark applications. The latest application filed is for "GAVRETO"
State Incorporated | DELAWARE |
Entity Type | CORPORATION |
Address | 45 Sidney Street Cambridge, MASSACHUSETTS UNITED STATES 02139 |
Patent Application | Date |
---|---|
SALT AND CRYSTAL FORMS OF AN ACTIVIN RECEPTOR-LIKE KINASE INHIBITOR 20220281879 - 17/633440 Medendorp; Clare ;   et al. | 2022-09-08 |
PRKC FUSIONS 20220213553 - 17/581669 STRANSKY; Nicolas ;   et al. | 2022-07-07 |
RAF1 FUSIONS 20220205045 - 17/490712 STRANSKY; Nicolas ;   et al. | 2022-06-30 |
RET INHIBITOR FOR USE IN TREATING CANCER HAVING A RET ALTERATION 20220175773 - 17/377885 Evans Raab; Erica ;   et al. | 2022-06-09 |
PYRROLOTRIAZINE DERIVATIVES FOR TREATING KIT-AND PDGFRA-MEDIATED DISEASES 20220153748 - 17/602770 Kim; Joseph L. ;   et al. | 2022-05-19 |
NCAGE Code | 6NX60 | BLUEPRINT MEDICINES CORPORATION!DBA BLUEPRINT MEDICINES |
CAGE Code | 6NX60 | BLUEPRINT MEDICINES CORPORATION |
S.A.M. Registration | 6NX60 [21905363] | BLUEPRINT MEDICINES CORPORATION |
SEC | 0001597264 | Blueprint Medicines Corp of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.